173 related articles for article (PubMed ID: 32806316)
1. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
Mohsen K; Azzazy HME; Allam NK; Basalious EB
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
[TBL] [Abstract][Full Text] [Related]
2. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study.
Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38376620
[TBL] [Abstract][Full Text] [Related]
3. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
Rashed HM; Shamma RN; Basalious EB
Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
[TBL] [Abstract][Full Text] [Related]
4. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
[TBL] [Abstract][Full Text] [Related]
5. Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality.
Bseiso EA; AbdEl-Aal SA; Nasr M; Sammour OA; El Gawad NAA
Drug Deliv; 2022 Dec; 29(1):2469-2480. PubMed ID: 35892291
[TBL] [Abstract][Full Text] [Related]
6. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
[No Abstract] [Full Text] [Related]
7. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
9. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
12. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line.
Molaahmadi MR; Varshosaz J; Taymouri S; Akbari V
Iran J Pharm Res; 2019; 18(4):1676-1693. PubMed ID: 32184838
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
[TBL] [Abstract][Full Text] [Related]
14. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
Bruinsmann FA; de Cristo Soares Alves A; de Fraga Dias A; Lopes Silva LF; Visioli F; Raffin Pohlmann A; Figueiró F; Sonvico F; Stanisçuaski Guterres S
Int J Pharm; 2022 Mar; 616():121563. PubMed ID: 35151819
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
[TBL] [Abstract][Full Text] [Related]
20. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
